Bateman, D NicholasDear, James WThanacoody, H K RubenThomas, Simon H LEddleston, MichaelSandilands, Euan ACoyle, JudyCooper, Jamie GRodriguez, AryellyButcher, IsabellaLewis, Steff CVliegenthart, A D BastiaanVeiraiah, AravindanWebb, David JGray, Alasdair2014-12-232014-12-232014-02-22Bateman, D N, Dear, J W, Thanacoody, H K R, Thomas, S H L, Eddleston, M, Sandilands, E A, Coyle, J, Cooper, J G, Rodriguez, A, Butcher, I, Lewis, S C, Vliegenthart, A D B, Veiraiah, A, Webb, D J & Gray, A 2014, 'Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning : a randomised controlled trial', The Lancet, vol. 383, no. 9918, pp. 697-704. https://doi.org/10.1016/S0140-6736(13)62062-00140-6736ORCID: /0000-0003-3812-7026/work/188766610http://hdl.handle.net/2164/4126Copyright © 2014 Bateman et al. Open Access article distributed under the terms of CC BY. Published by Elsevier Ltd. All rights reserved. The trial was funded by Chief Scientist Office, Scotland (award CZB/4/722).8415339engAcetaminophenAcetylcysteineAdultAgedAlanine TransaminaseAntiemeticsDouble-Blind MethodDrug Administration ScheduleDrug Therapy, CombinationFemaleGreat BritainHumansInfusions, IntravenousLiver Failure, AcuteMaleMiddle AgedNauseaOndansetronPoisoningTreatment OutcomeVomitingR MedicineRJournal article10.1016/S0140-6736(13)62062-03839918